These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 16713027)
1. [Recent advances in the treatment of myelodysplastic syndromes]. Gelsi-Boyer V; Vey N Rev Med Interne; 2006 Aug; 27(8):600-9. PubMed ID: 16713027 [TBL] [Abstract][Full Text] [Related]
2. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies]. Aul C; Giagounidis A; Germing U; Ganser A Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275 [TBL] [Abstract][Full Text] [Related]
4. Myelodysplasia: when to treat and how. Larson RA Best Pract Res Clin Haematol; 2006; 19(2):293-300. PubMed ID: 16516126 [TBL] [Abstract][Full Text] [Related]
5. Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes. Stankov K; Stankov S; Katanic J Curr Pharm Des; 2017; 23(1):135-169. PubMed ID: 27697023 [TBL] [Abstract][Full Text] [Related]
6. The myelodysplastic syndromes: the era of understanding. Meers S Eur J Haematol; 2015 May; 94(5):379-90. PubMed ID: 25186093 [TBL] [Abstract][Full Text] [Related]
16. Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends. Stahl M; Zeidan AM Expert Rev Hematol; 2017 Apr; 10(4):345-364. PubMed ID: 28277851 [TBL] [Abstract][Full Text] [Related]
17. New Insights into the Pathogenesis of MDS and the rational therapeutic opportunities. Abou Zahr A; Bernabe Ramirez C; Wozney J; Prebet T; Zeidan AM Expert Rev Hematol; 2016; 9(4):377-88. PubMed ID: 26734762 [TBL] [Abstract][Full Text] [Related]
18. Treatment of adult myelodysplastic syndromes. Hellström-Lindberg E Int J Hematol; 1999 Oct; 70(3):141-54. PubMed ID: 10561906 [TBL] [Abstract][Full Text] [Related]